
Liebigs Annalen p. 41 - 47 (1997)
Update date:2022-08-05
Topics:
Ogrel, Alexei
Bloemhoff, Wim
Lugtenburg, Johan
Raap, Jan
The isotopically labelled C-terminal fragment of zervamicin, H-Hyp10-[4,4-2H2-Gln]-Aib-Hyp-Aib-Pro-Phl 16, has been synthesized in solution by a Fmoc/tert-butyl strategy in 28% overall yield. The Fmoc group was removed by reaction for 2 min with 0.1 M NaOH in dioxane/methanol/water, (30:9:1, v:v:v). The couplings of the sterically hindered Aib residues were achieved by means of either BOP/DMAP activation or Fmoc-Aib-Cl. Acid deprotection of the peptide was performed by reaction with 50% TFA in CH2Cl2 for 30 min without significant cleavage of the acid-labile Aib-Pro and Aib-Hyp peptide bonds. VCH Verlagsgcsellschaft mbH, 1997.
View MoreShanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
China Synchem Technology Co.,Ltd
website:http://www.cnsynchem.com
Contact:+86-0552-4929311
Address:No.217 Daqing Road
Hebei Kangtai Pharmaceutical Co.,Ltd
Contact:+86-0317-3512963
Address:Wugang Road,Mengcun of Cangzhou City,Hebei Province ,China
Shandong Xinhua Pharmaceutical Co.,Ltd
website:http://www.xhzy.com
Contact:+86-533-2196801
Address:1 lutai road,zhangdian dis,Zibo City
Doi:10.1002/chem.200400358
(2004)Doi:10.1021/ja01099a047
(1953)Doi:10.1016/S0040-4020(01)99384-6
(1973)Doi:10.1002/1521-3773(20010105)40:1<207::AID-ANIE207>3.0.CO;2-K
(2001)Doi:10.1002/adsc.201900949
(2019)Doi:10.1021/jo00241a032
(1988)